Report overview
Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
This report aims to provide a comprehensive presentation of the global market for Female Infertility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Infertility Drugs. This report contains market size and forecasts of Female Infertility Drugs in global, including the following market information:
Global Female Infertility Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Female Infertility Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The adverse effects and high cost of non-therapeutics will also boost the popularity of female infertility drugs. Various ART procedures, including IVF, IUI, and ICSI are available as alternatives to medications for the treatment of female infertility.
We surveyed the Female Infertility Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Infertility Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Female Infertility Drugs Market Segment Percentages, by Type, 2022 (%)
Parenteral
Oral
Others
Global Female Infertility Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Female Infertility Drugs Market Segment Percentages, by Application, 2022 (%)
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
Global Female Infertility Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Female Infertility Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Infertility Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Female Infertility Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Female Infertility Drugs, market overview.
Chapter 2: Global Female Infertility Drugs market size in revenue.
Chapter 3: Detailed analysis of Female Infertility Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Female Infertility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
